These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36193399)

  • 1. The "Booster" of Corporate Eco-Innovation: Government Pressure Perceived by Chinese Private Firms.
    Li C
    J Environ Public Health; 2022; 2022():2337867. PubMed ID: 36193399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional pressures as drivers of corporate green innovation: do provincial officials and CEOs matter?
    Ren S; Wang M
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):40608-40629. PubMed ID: 36622586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Entrepreneurs' Military Experience Promote Corporate Environmental Investment? Evidence from Chinese Private Firms.
    Hong C; Yan Y; Zhang X
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How geographic diversification affects corporate social responsibility? The moderating effects of ownership and environmental regulation.
    Zhang Y; Peng X; Li Y; Fu S
    Environ Sci Pollut Res Int; 2022 Nov; 29(54):81658-81669. PubMed ID: 35732896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does Chinese central environmental inspection affect corporate green innovation? The moderating effect of bargaining intentions.
    Zhang Z; Peng X; Yang L; Lee S
    Environ Sci Pollut Res Int; 2022 Jun; 29(28):42955-42972. PubMed ID: 35092589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental regulation, digital finance, and technological innovation: evidence from listed firms in China.
    Yang Y; Li X
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):44625-44639. PubMed ID: 36696056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corporate governance and reporting quality of accounts in China-listed firms. A moderating role of ownership pattern.
    Sun H
    PLoS One; 2023; 18(11):e0295253. PubMed ID: 38033159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-interest or altruism: Entrepreneurs' military experience and the motivation of corporate philanthropic donations.
    Chen H; Wu H; Li H
    Front Psychol; 2022; 13():917289. PubMed ID: 36562060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Officials' promotion expectation, corporate strategic deviance and corporate growth in China: The moderating effect of corporate ownership.
    Li Y; Fang X
    PLoS One; 2023; 18(8):e0284872. PubMed ID: 37624770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of energy consumption structure transformation on firms' total factor productivity: evidence from China.
    Zhang Z; Ma Y
    Environ Sci Pollut Res Int; 2023 Jul; 30(31):76950-76968. PubMed ID: 37249767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distance matters: Investigating how geographic proximity to ENGOs triggers green innovation of heavy-polluting firms in China.
    Hu C; Mao J; Tian M; Wei Y; Guo L; Wang Z
    J Environ Manage; 2021 Feb; 279():111542. PubMed ID: 33162234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doing Good Again? A Multilevel Institutional Perspective on Corporate Environmental Responsibility and Philanthropic Strategy.
    Liu W; Wei Q; Huang SQ; Tsai SB
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29064451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Transformation and Green Innovation of Chinese Firms: The Moderating Role of Regulatory Pressure and International Opportunities.
    He J; Su H
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of government subsidies on innovation of Chinese biopharmaceutical firms: Based on kink threshold model.
    Li Q; Di J; Liu Q
    Front Public Health; 2023; 11():1087830. PubMed ID: 36908409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pandemics on Corporate Innovation: Evidence From the Chinese Firms.
    Zhang C; Hu Y; Huang L; Huang Y
    Front Public Health; 2021; 9():780348. PubMed ID: 34805086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Employee Stock Ownership Plans Affect Corporate Social Responsibility? Evidence from China.
    Zhou L; Wei F; Kong Y
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China's Carbon Emissions and Trading Pilot, Political Connection, and Innovation Input of Publicly Listed Private Firms.
    Liu W; Yu C; Cheng S; Xu J; Wu Y
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between perceived institutional conditions and firm-level innovations in emerging markets: Moderating effects of firm ownerships.
    Odei SA
    PLoS One; 2024; 19(1):e0291290. PubMed ID: 38252618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Managerial Ties Help or Hinder Corporate Green Innovation? The Moderating Roles of Contextual Factors.
    Zhang Y; Wang Y
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental legislation and capitalization of corporate environmental expenditure: Evidence from China.
    Wang T; Chen Y
    PLoS One; 2022; 17(11):e0277258. PubMed ID: 36327347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.